Genmab
Joris van Sadelhoff is a scientific writer at Genmab since May 2022, following a successful tenure as a PhD candidate at Universiteit Utrecht from May 2018 to April 2022, where research focused on the immunological functions of human milk free amino acids. Prior experience includes a PhD candidacy and junior scientist role at Danone Nutricia Research, concentrating on the immunomodulating properties of free amino acids, alongside internships in immunology, market analysis, and developmental biology. Joris holds a PhD in Immunology from Utrecht University, as well as multiple master's degrees in Molecular Life Science and Science, Management, and Innovation from Radboud University. Key achievements include securing a Future Food Utrecht seed grant and being a finalist in the Industrial Doctorates Programme for PhD funding.
This person is not in any teams
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.